Schonfeld Strategic Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,824
Closed -$122K 2213
2025
Q4
$122K Buy
+10,824
New +$124K ﹤0.01% 1790
2025
Q3
Sell
-27,739
Closed -$340K 2197
2025
Q2
$340K Buy
+27,739
New +$349K ﹤0.01% 1660
2024
Q2
Sell
-11,934
Closed -$238K 2147
2024
Q1
$238K Buy
+11,934
New +$231K ﹤0.01% 1734
2022
Q4
Sell
-27,358
Closed -$597K 2581
2022
Q3
$597K Buy
+27,358
New +$715K 0.01% 1625
2022
Q2
Sell
-11,700
Closed -$392K 2525
2022
Q1
$392K Buy
+11,700
New +$377K ﹤0.01% 1522
2020
Q4
Sell
-69,544
Closed -$2.31M 1567
2020
Q3
$2.31M Buy
69,544
+3,142
+5% +$100K 0.04% 466
2020
Q2
$1.95M Buy
+66,402
New +$1.92M 0.05% 411
2020
Q1
Sell
-239,772
Closed -$8.08M 1140
2019
Q4
$8.08M Buy
+239,772
New +$8.68M 0.2% 132
2018
Q4
Sell
-104,100
Closed -$7.13M 1051
2018
Q3
$7.13M Sell
104,100
-45,900
-31% -$2.95M 0.32% 81
2018
Q2
$8.59M Sell
150,000
-31,575
-17% -$1.67M 0.47% 40
2018
Q1
$8.37M Buy
181,575
+13,477
+8% +$640K 0.63% 24
2017
Q4
$7.76M Buy
168,098
+83,954
+100% +$3.86M 0.64% 26
2017
Q3
$3.79M Buy
+84,144
New +$3.59M 0.35% 94

Other funds holding AVNS

Schonfeld Strategic Advisors's AVNS Position: Q1 2026 in Review

Schonfeld Strategic Advisors sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 10,824 shares — an estimated $122K sold.

Schonfeld Strategic Advisors first reported a position in AVNS in Q3 2017 and held it in 13 quarters. The position peaked at $8.59M in Q2 2018. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.

  • Schonfeld Strategic Advisors reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 10,824 Avanos Medical shares in Q1 2026, an estimated $122K.
  • Schonfeld Strategic Advisors first reported a position in Avanos Medical in Q3 2017 and held it in 13 quarters.
  • Schonfeld Strategic Advisors's Avanos Medical position peaked at $8.59M in Q2 2018.
  • 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.